Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.
Transplant Cell Ther
; 27(3): 244.e1-244.e8, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33781522
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heterocyclic Compounds
/
Multiple Myeloma
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Transplant Cell Ther
Year:
2021
Type:
Article
Affiliation country:
Italy